tiprankstipranks
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
US Market

BioRestorative Therapies (BRTX) Financial Statements

Compare
185 Followers

BioRestorative Therapies Financial Overview

BioRestorative Therapies's market cap is currently $12.46M. The company's EPS TTM is $-0.714; its P/E ratio is ―; BioRestorative Therapies is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 145.80K$ 119.80K$ 46.00K$ 77.00K$ 130.00K
Gross Profit$ 145.80K$ -160.87K$ -159.21K$ 77.00K$ 130.00K
Operating Income$ -15.22M$ -18.97M$ -26.31M$ -2.75M$ -8.43M
EBITDA$ -15.06M$ -18.85M$ -26.22M$ -9.48M$ -9.29M
Net Income$ -10.42M$ -18.02M$ -29.94M$ -12.25M$ -17.92M
Balance Sheet
Cash & Short-Term Investments$ 11.07M$ 14.75M$ 21.03M$ 3.06M$ 1.66K
Total Assets$ 12.61M$ 16.43M$ 22.45M$ 4.35M$ 1.47M
Total Debt$ 162.32K$ 301.64K$ 670.70K$ 4.79M$ 7.75M
Net Debt$ -722.06K$ -1.37M$ -20.36M$ 1.73M$ 7.75M
Total Liabilities$ 2.61M$ 602.62K$ 856.50K$ 5.68M$ 14.24M
Stockholders' Equity$ 10.00M$ 15.83M$ 21.60M$ -1.33M$ -12.78M
Cash Flow
Free Cash Flow$ -6.60M$ -6.31M$ -3.36M$ -1.96M$ -6.95M
Operating Cash Flow$ -6.43M$ -5.87M$ -3.33M$ -1.96M$ -6.92M
Investing Cash Flow$ 3.25M$ -13.48M$ -30.66K$ 0.00$ -35.63K
Financing Cash Flow$ 2.35M$ 0.00$ 21.32M$ 5.03M$ 6.84M
Currency in USD

BioRestorative Therapies Earnings and Revenue History

BioRestorative Therapies Debt to Assets

BioRestorative Therapies Cash Flow

BioRestorative Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis